FDA Inspection
Centrient Pharmaceuticals India Private LimitedCentrient Pharmaceuticals India Private Limited – FDA Inspection, Jan 27, 2026
Record Details
This FDA Inspection record concerns Centrient Pharmaceuticals India Private Limited, with an inspection on January 27, 2026, issued by the Office of Inspections and Investigations, covering human drugs.
- Inspection Date
- January 27, 2026
- Product Type
- Human Drugs
View Company Profile
ID · 7060b154-374c-4d34-a8d1-8b909c08e198
Inspection Facts
- Inspection number
- 1310126
- FDA center
- Human Drugs
Other FDA inspections of Centrient Pharmaceuticals India Private Limited
3| Date | Classification | Office | Project area |
|---|---|---|---|
| July 1, 2022 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 20, 2018 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 18, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Centrient Pharmaceuticals India Private Limited
- FDA Inspection 1175790 - 2022-07-01
- FDA Inspection 1050153 - 2018-04-20
- FDA Inspection 954842 - 2015-12-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.